The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C

Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis, and natural killer cell counts

(2010) Yung-Che Chen et al.   BMC Medical Genetics

Impact of Toll-like receptors [TLR] 2 (−196 to −174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women

(2009) Saumya Pandey et al.   GYNECOLOGIC ONCOLOGY

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis

(2009) Sara Raimondi et al.   JOURNAL OF HEPATOLOGY

Tumor Suppressors, Chromosomal Instability, and Hepatitis C Virus–Associated Liver Cancer

(2008) David R. McGivern et al.   Annual Review of Pathology-Mechanisms of Disease

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

(2008) Anna S. Lok et al.   GASTROENTEROLOGY

Polymorphisms in Toll-like receptor genes and risk of cancer

(2008) E M El-Omar et al.   ONCOGENE